IOVS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ikuno, Y.
Right arrow Articles by Kazlauskas, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ikuno, Y.
Right arrow Articles by Kazlauskas, A.
(Investigative Ophthalmology and Visual Science. 2002;43:41-46.)
© 2002 by The Association for Research in Vision and Ophthalmology, Inc.

TGFß1-Dependent Contraction of Fibroblasts Is Mediated by the PDGF{alpha} Receptor

Yasushi Ikuno and Andrius Kazlauskas

From the Department of Ophthalmology, The Schepens Eye Research Institute, Harvard Medical School, Boston, Massachusetts.

PURPOSE. Contraction of fibroblasts and the resultant tractional force is a contributing factor to fibrotic diseases of the eye, such as proliferative vitreoretinopathy (PVR). Transforming growth factor (TGF)-ß is abundant in the eye, and is one of the growth factors thought to contribute to the development of PVR. A second is platelet-derived growth factor (PDGF). In the current study, the relationship between TGFß1 and PDGF was investigated at the level of cellular contraction.

METHODS. To study cellular contraction, an in vitro type I collagen gel contraction assay was used with a panel of fibroblast lines that expressed the PDGF{alpha} receptor ({alpha}PDGFR) or PDGFß receptor (ßPDGFR) or no PDGFRs. The agents tested included rabbit vitreous, TGFß1, and PDGF.

RESULTS. Vitreous promoted cellular contraction, and approximately 60% of this activity was eliminated by preincubation of the vitreous with neutralizing TGFß antibodies. The {alpha}PDGFR-expressing cells responded better than cells expressing the ßPDGFR or no PDGFRs. Both of the PDGFR-expressing cell lines contracted in response to PDGF, whereas the best response to TGFß1 was observed with cells expressing the {alpha}PDGFR. Finally, TGFß1 promoted the tyrosine phosphorylation of both of the PDGFRs, and the {alpha}PDGFR was more strongly phosphorylated than the ßPDGFR.

CONCLUSIONS. The results show that the vitreous promotes cellular contraction, that TGFß is the major factor responsible, and that at least a portion of the TGFß-dependent contraction proceeds through the {alpha}PDGFR—that is, indirectly. Therefore, the {alpha}PDGFR is responsible for mediating cellular contraction of multiple growth factors: TGFß and members of the PDGF family.




This article has been cited by other articles:


Home page
Endocr Relat CancerHome page
M. Brama, S. Basciani, S. Cherubini, S. Mariani, S. Migliaccio, M. Arizzi, G. Rosano, G. Spera, and L. Gnessi
Osteoblast-conditioned medium promotes proliferation and sensitizes breast cancer cells to imatinib treatment
Endocr. Relat. Cancer, March 1, 2007; 14(1): 61 - 72.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
Y. Zheng, H. Bando, Y. Ikuno, Y. Oshima, M. Sawa, M. Ohji, and Y. Tano
Involvement of Rho-Kinase Pathway in Contractile Activity of Rabbit RPE Cells In Vivo and In Vitro
Invest. Ophthalmol. Vis. Sci., February 1, 2004; 45(2): 668 - 674.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
Y. Nakamura, S. Hirano, K. Suzuki, K. Seki, T. Sagara, and T. Nishida
Signaling Mechanism of TGF-{beta}1-Induced Collagen Contraction Mediated by Bovine Trabecular Meshwork Cells
Invest. Ophthalmol. Vis. Sci., November 1, 2002; 43(11): 3465 - 3472.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
Y. Ikuno and A. Kazlauskas
An In Vivo Gene Therapy Approach for Experimental Proliferative Vitreoretinopathy Using the Truncated Platelet-Derived Growth Factor {alpha} Receptor
Invest. Ophthalmol. Vis. Sci., July 1, 2002; 43(7): 2406 - 2411.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2002 by the Association for Research in Vision and Ophthalmology